Data / Form D filings / VISIONGATE INC
VISIONGATE INC: Form D filings
VISIONGATE INC, a biotechnology company in Phoenix, AZ, filed 19 Form D notices with the SEC between 2009 and 2019. The latest, on December 17, 2019, reports $36.6 million sold of a $43 million offering to 83 investors.
Find out what VISIONGATE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10220 S. 51ST STREET, SUITE 2, Phoenix, AZ, 85044
- Phone
- (602) 368-2118
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1339362
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 17, 2019 | Amendment | $43,000,001 | $36,563,440 | $6,436,561 | 83 | Jun 6, 2013 | sec.gov |
| Aug 22, 2019 | New notice | $10,000,000 | $3,748,247 | $6,251,753 | 43 | Jun 6, 2019 | sec.gov |
| Dec 19, 2018 | Amendment | $43,000,001 | $33,535,586 | $9,464,415 | 73 | Jun 6, 2013 | sec.gov |
| Dec 20, 2017 | Amendment | $35,000,000 | $26,064,119 | $8,935,881 | 62 | Jun 6, 2013 | sec.gov |
| Jun 26, 2017 | Amendment | $27,000,000 | $24,285,945 | $2,714,055 | 79 | Jun 6, 2013 | sec.gov |
| Nov 21, 2016 | Amendment | $24,000,000 | $15,048,042 | $8,951,958 | 42 | Jun 6, 2013 | sec.gov |
| May 10, 2016 | Amendment | $20,000,000 | $11,179,852 | $8,820,148 | 36 | Jun 6, 2013 | sec.gov |
| Apr 14, 2016 | Amendment | $5,500,000 | $5,332,200 | $167,800 | 18 | Sep 30, 2014 | sec.gov |
| Sep 22, 2015 | Amendment | $4,000,000 | $3,753,500 | $246,500 | 17 | Sep 30, 2014 | sec.gov |
| May 26, 2015 | Amendment | $12,025,000 | $6,206,206 | $5,818,794 | 25 | Jun 6, 2013 | sec.gov |
| Oct 10, 2014 | New notice | $3,000,000 | $800,000 | $2,200,000 | 2 | Sep 30, 2014 | sec.gov |
| Jun 10, 2014 | Amendment | $12,025,000 | $4,847,253 | $7,177,747 | 14 | Jun 6, 2013 | sec.gov |
| Jun 13, 2013 | New notice | $12,025,000 | $800,000 | $11,225,000 | 1 | Jun 6, 2013 | sec.gov |
| Sep 21, 2012 | Amendment | $8,000,000 | $4,363,073 | $3,636,927 | 61 | Sep 6, 2010 | sec.gov |
| Jul 24, 2012 | Amendment | $8,000,000 | $4,149,073 | $3,850,927 | 56 | Sep 6, 2010 | sec.gov |
| Oct 11, 2011 | Amendment | $3,000,000 | $1,960,278 | $1,039,722 | 29 | Sep 6, 2010 | sec.gov |
| Oct 12, 2010 | New notice | $3,000,000 | $125,000 | $2,875,000 | 2 | Sep 6, 2010 | sec.gov |
| Sep 1, 2009 | Amendment | $3,500,000 | $1,780,000 | $1,720,000 | 17 | Jan 20, 2008 | sec.gov |
| Apr 10, 2009 | New notice | $1,200,000 | $490,000 | $710,000 | 6 | Nov 6, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tanisha June-Nichole S. Villanueva | Executive Officer | |
| Michael S. Doherty | Director | |
| Alan C. Nelson | Executive Officer, Director | |
| Maria C. Forero | Director | |
| Walter C. Robb | Director | |
| James S. Burns | Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Dec 16, 2019 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VISIONGATE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.